G01N 2333/155
Lentiviridae
Official title: Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
G01N2333/155 (Lentiviridae) appears on 529 US grants and 600 published applications in this corpus.
Search patents in G01N- Granted patents
- 529
- Published applications
- 600
- Assignees
- 342
- Inventors
- 1,217
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 5 | 0 |
| 1996 | 11 | 0 |
| 1997 | 33 | 0 |
| 1998 | 42 | 0 |
| 1999 | 20 | 0 |
| 2000 | 19 | 0 |
| 2001 | 25 | 6 |
| 2002 | 14 | 17 |
| 2003 | 18 | 44 |
| 2004 | 13 | 29 |
| 2005 | 11 | 46 |
| 2006 | 14 | 32 |
| 2007 | 20 | 21 |
| 2008 | 14 | 33 |
| 2009 | 15 | 26 |
| 2010 | 18 | 39 |
| 2011 | 17 | 25 |
| 2012 | 16 | 23 |
| 2013 | 13 | 19 |
| 2014 | 11 | 19 |
| 2015 | 13 | 26 |
| 2016 | 11 | 27 |
| 2017 | 21 | 24 |
| 2018 | 17 | 22 |
| 2019 | 24 | 18 |
| 2020 | 20 | 18 |
| 2021 | 10 | 21 |
| 2022 | 10 | 12 |
| 2023 | 10 | 8 |
| 2024 | 12 | 18 |
| 2025 | 6 | 21 |
| 2026 | 7 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Anti-human immunodeficiency virus-1 antibodies and methods for uses thereof29 Sep 2026US 12,747,285 B2Grifols Diagnostic Solutions Inc.
- Anti-CD32A antibodies and their use for evaluating the presence of a viral reservoir16 Jun 2026US 12,656,335 B2Centre National De La Recherche Scientifique
- Live imaging system to visualize the retro-transcribed viral DNA genome28 Apr 2026US 12,613,239 B2Institut Pasteur
- Methods of identifying HIV patients sensitive to therapy with gp120 CD4 binding site-directed antibodies24 Feb 2026US 12,559,546 B2Gilead Sciences, Inc.
- Neutralizing antibodies to GP120 and their use10 Feb 2026US 12,545,719 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Tcr-mimic bispecific antibodies for hiv-11 Oct 2026US 2026/0297193 A1The Johns Hopkins University
- Assays and reagents for the detection of soluble gp12027 Aug 2026US 2026/0251654 A1
- Anti-hiv antibodies30 Jul 2026US 2026/0217801 A1International AIDS Vaccine Initiative
- Antibody against human immunodeficiency virus type 1 p24 and type 2 p26 and uses thereof30 Apr 2026US 2026/0118359 A1Hytest Ltd.
- Sexually Transmitted Infection Testing from Human Dried Blood Spots Collected Remotely26 Mar 2026US 2026/0086092 A1
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997
- High-affinity nucleic acid ligands that discriminate between theophylline and caffeine277US 5,580,737 ANeXstar Pharmaceuticals, Inc. · 1996